Table 3 Multivariate COX proportional hazards analysis to identify predictors of heart failure-related events using forced inclusion models
From: The role of Asprosin in patients with dilated cardiomyopathy
Variable | Model 1 | Model 2 | Model 3 | |||
|---|---|---|---|---|---|---|
HR (95% CI) | P value | HR (95% CI) | P value | HR (95% CI) | P value | |
Asprosin, (< 120 vs ≥120 ng/mL) | 10.53 (2.18–50.81) | 0.003 | 8.72 (1.90–39.97) | 0.005 | 7.13 (1.51–33.69) | 0.013 |
Age, y | 0.92 (0.85–0.99) | 0.026 | – | – | ||
LVEF, % | – | 0.91 (0.84–0.99) | 0.036 | – | ||
Cholesterol, mg/dL | – | – | 0.97 (0.94–0.99) | 0.02 | ||